United Orthopedic Corporation (TPEX:4129)

Market Cap	9.74B +8.8%
Revenue (ttm)	5.66B +21.5%
Net Income	562.50M +23.2%
EPS	5.67 +19.6%
Shares Out	96.44M
PE Ratio	17.81
Forward PE	14.48
Dividend	4.00 (3.96%)
Ex-Dividend Date	Jul 23, 2025

Volume	290,860
Average Volume	289,101
Open	102.00
Previous Close	101.50
Day's Range	100.00 - 102.00
52-Week Range	77.30 - 131.50
Beta	0.46
RSI	36.19
Earnings Date	May 8, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.50 million, an increase of 23.37%.